Product Images Oxcarbazepine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 14 images provide visual information about the product associated with Oxcarbazepine NDC 60687-733 by American Health Packaging, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

150 mg Oxcarbazepine Tablet Blister - 150 mg Blister

150 mg Oxcarbazepine Tablet Blister - 150 mg Blister

This appears to be a list of prescription drug labels for a medication called Oxcarbazepine in the form of tablets. The tablets contain 150mg of the medication. The labels appear to have been printed with inconsistent formatting, including variations in capitalization and spacing, which may make it difficult to accurately identify the medication's instructions, warnings, or potential side effects.*

150 mg Oxcarbazepine Tablets Carton - 150 mg Carton

150 mg Oxcarbazepine Tablets Carton - 150 mg Carton

NDC 60687-711-01 is a medication containing Oxcarbazepine in tablet form. It comes in a bottle of 100 film-coated tablets, with each tablet containing 150mg of the active ingredient. The recommended dosage can be found on the packaging. The medication should be stored at room temperature between 20° and 25°C (68° and 77°F). This medication should be kept out of reach of children and not used if the seal is broken. It is distributed by American Health Packaging in Columbus, Ohio.*

300 mg Oxcarbazepine Tablet Blister - 300 mg Blister

300 mg Oxcarbazepine Tablet Blister - 300 mg Blister

300 mg Oxcarbazepine Tablets Carton - 300 mg Carton

300 mg Oxcarbazepine Tablets Carton - 300 mg Carton

Oxcarbazepine is a medicine available in the form of Tablets, USP, containing 100 tablets per pack. The tablets are film-coated and contain 600mg of Ghcarbazepine USP each. The usual dosage instructions can be found in the package insert. The medicine should be stored between 20-26°C (68-77°F) with excursions permitted between 15-30°C (59-86°F). It should be kept out of reach of children, and blister packs should not be used if they are torn or broken. The medicine is distributed by American Health Packaging, based in Columbus, Ohio. The National Drug Code (NDC) for this product is 60687-722-01. The accompanying Medication Guide should be given to each patient.*

600 mg Oxcarbazepine Tablet Blister - 600 mg Blister

600 mg Oxcarbazepine Tablet Blister - 600 mg Blister

600 mg Oxcarbazepine Tablets Carton - 600 mg Carton

600 mg Oxcarbazepine Tablets Carton - 600 mg Carton

This is a description of a medication called Oxcarbazepine which comes in the form of tablets. The tablets come in a bottle with 100 tablets which is an equivalent of 10 x 10 packs. The suggested dosage is contained in the package insert. It should be stored at the temperature between 15°C to 30°C. The medication is to be kept out of reach of children and not to be used if the blister is torn or broken. The name of the manufacturer is Camber Pharmaceuticals, Inc. The medication is distributed by American Health Packaging. The NDC code for the medication is 60687-733-01.*

AHP71101

AHP71101

AHP72201

AHP72201

AHP73301

AHP73301

Figure 1: Kaplan-Meier Estimates of Exit Rate by Treatment Group - Figure1

Figure 1: Kaplan-Meier Estimates of Exit Rate by Treatment Group - Figure1

The log-rank test was performed with a p-value of 0.0001. The table shows the time on trial from Day 2 to Day 11 for the Oxcarbarspine treatment group.*

Figure 2: Kaplan-Meier Estimates of First Seizure Event Rate by Treatment Group - Figure2

Figure 2: Kaplan-Meier Estimates of First Seizure Event Rate by Treatment Group - Figure2

Figure 3: Kaplan-Meier Estimates of Exit Rate by Treatment Group - Figure3

Figure 3: Kaplan-Meier Estimates of Exit Rate by Treatment Group - Figure3

The given text provides the result of the log-rank test which is a statistical hypothesis test to compare the survival distributions of two groups. The p-value mentioned is 0.0001 which suggests that there is a significant difference between the groups being compared. The rest of the text seems to be an unrelated gibberish due to errors.*

Figure 4: Kaplan-Meier Estimates of Exit Rate by Treatment Group - Figure4

Figure 4: Kaplan-Meier Estimates of Exit Rate by Treatment Group - Figure4

This is a statistical output from a log-rank test showing the p-value to be 0.0001. The rest of the text is not clear but seems to refer to a study or experiment involving a group receiving some sort of treatment which is labeled "HIGH" and "LOW". The x-axis shows a time scale up to 130 days.*

Structural Formula - Structure

Structural Formula - Structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.